Salon Today
JUNE 5, 2024
As the weather warms up, many Americans are planning their summer getaways, but sadly fewer Americans are taking full advantage of their vacation time. Our Wellness Blogger Mary Wilson outlines why it's important to give yourself a vacation.
MedEsthetics
JUNE 5, 2024
Kenvue highlighted 22 clinical findings from studies presented at this year's AAD. Topics included oats and the microbiome, NMF + lipids for a skin barrier boost, ZnO skin protection, acne care hydrocolloid patches, TXA + niacinamide, anti-aging and more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Dermatology Digest
JUNE 5, 2024
A high-sodium diet may increase the risk of eczema, according to researchers at University of California, San Francisco (UCSF). Eating just one extra gram of sodium per day increases the likelihood of flares by 22%, the researchers report. In the cross-sectional study, researchers analyzed data from more than 215,000 people aged 30 to 70 from the UK Biobank, which includef urine samples and electronic medical records.
Dermatology Times
JUNE 5, 2024
Henry Lim, MD, discusses key findings and areas of improvement identified by the report, as well as his hopes for HS treatment moving forward.
The Dermatology Digest
JUNE 5, 2024
Lumenis Be. Ltd. is introducing FoLix , the first fractional laser to treat hair loss. Recently cleared by the U.S. Food and Drug Administration, FoLix is a non-ablative fractional laser device to improve the appearance of scalp hair in adult males and females with Fitzpatrick skin types I to IV, who are seeking treatment for hair loss. Pre-clinical and clinical studies showed a positive impact on hair growth, with noticeable improvements in scalp hair appearance and an increase in hair count, &
Dermatology Times
JUNE 5, 2024
Robin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
MedEsthetics
JUNE 5, 2024
96% of readers are interested in non-invasive treatment advances for blepharoplasty procedures! Here are three exciting advances in non-invasive blepharoplasty (eyelid lift) procedures.
Dermatology Times
JUNE 5, 2024
Session at the 2024 SDPA Annual Summer Dermatology Conference helps clinicians reframe beauty and empower patients.
MedEsthetics
JUNE 5, 2024
Are you interested in novel advances in AI imaging for skin cancer detection and tracking? Answer our 1-question survey and let us know!
Dermatology Times
JUNE 5, 2024
The primary efficacy endpoint is the proportion of subjects achieving at least a 50% improvement in the Facial Vitiligo Area Scoring Index.
Lira Clinical
JUNE 5, 2024
Skin Depth Convo hosts and Lira Clinical owners Metaxia and Francine are joined by guests Michael Moore and George Gallegos to discuss finding support and empowerment as men in the skincare industry. Men are carving out their space long dominated by women. Discuss the shift of an increased presence of men in skincare. Skin Depth Convo hosts and Lira Clinical owners Metaxia and Francine are joined by guests Michael Moore and George Gallegos to discuss finding support and empowerment as men in the
Dermatology Times
JUNE 5, 2024
Researchers found dupilumab improved itch and skin lesions regardless of atopic disease status in patients with PN.
Mindbody
JUNE 5, 2024
Staying ahead of AI trends and learn how to delegate tasks to AI to revolutionize your fitness and wellness businesses and create better client experiences.
Dermatology Times
JUNE 5, 2024
Click here to answer today's poll and read more about providing patients with multidisciplinary care.
Mindbody
JUNE 5, 2024
Staying ahead of AI trends and learn how to delegate tasks to AI to revolutionize your fitness and wellness businesses and create better client experiences.
Beauty Launchpad
JUNE 5, 2024
Get to know Nicolette Renteria (@rentedhair). She is a hairstylist, specializing in curly cuts.
Mindbody
JUNE 5, 2024
Staying ahead of AI trends and learn how to delegate tasks to AI to revolutionize your fitness and wellness businesses and create better client experiences.
Beauty Launchpad
JUNE 5, 2024
When it comes to stylist longevity, long hours behind the chair without caring for one's personal comfort both physically and mentally can lead to disaster in the long run.
Mindbody
JUNE 5, 2024
Learn about the funding options available to you as a wellness business owner and how to secure capital for your long term growth.
Lipgloss and Aftershave
JUNE 5, 2024
Want a chance to win $2,600 in professional and retail, highly effective skin care products? Want to win a chance to meet Princess Isabella Orsini? Then you need to connect with Nelly De Vuyst at their Las Vegas IECSC booth #719 and during one of their 8 classes on 6/22 or 6/23 in classroom #W213. Thanks to Nelly De Vuyst for sponsoring this content so that we can share their Las Vegas IECSC offerings with the L+A Community.
Dermatology Times
JUNE 5, 2024
Turn Therapeutics' Bradley Burnam recently spoke with Dermatology Times.
Lipgloss and Aftershave
JUNE 5, 2024
Nothing is more valuable to education than practical on the job experience. If you are looking to grow your medical + spa skin care industry skill set – you will definitely want to sign up for L+A Summer School to gain access to 13 Webinars and 7 E-Books! Register for Summer School by providing your email address below. Then, check your inbox!
US Dermatologt Partners
JUNE 5, 2024
Okmulgee, Oklahoma – U.S. Dermatology Partners is pleased to announce the opening of its newest office location in Okmulgee, Oklahoma. U.S. Dermatology Partners expands access to dermatology care to patients in Okmulgee County with the opening of its newest office location. The new Okmulgee office is the latest addition to the organization’s Outreach Program , which is committed to serving rural and underserved communities.
The Dermatology Digest
JUNE 5, 2024
Abrocitinib (Cibinqo, Pfizer) improves the symptoms of prurigo nodularis and chronic pruritus of unknown origin, according to a new study in JAMA Dermatology. The 12-week study involved 20 patients, half of whom had prurigo nodularis and half of whom had chronic pruritus of unknown origin. They were all given a 200-milligram pill of abrocitinib once a day for 12 weeks.
Expert insights. Personalized for you.
111 
Let's personalize your content